Results 121 to 130 of about 22,504 (208)
Progress in Gastroparesis Management: From Pharmacotherapy to Interventional Treatments
ABSTRACT Gastroparesis is a sensorimotor condition characterized by delayed gastric emptying without any obvious mechanical obstruction. Common symptoms include early satiety, nausea, vomiting, belching, and bloating. The most frequent causes of gastroparesis are diabetes, idiopathic factors, and post‐surgical complications.
Ganesh Kumar +9 more
wiley +1 more source
The Japanese guideline and criteria for evaluating and determining the effects of psychotropic drugs on motor vehicle driving performance enable the clinical implementation of evidence by assessing “persistence of clinically meaningful impairment”. ABSTRACT The cross‐national differences in automobile driving precautions stated in psychotropic drug ...
Tetsuo Nakabayashi +9 more
wiley +1 more source
Abstract Background Valbenazine is used to treat dyskinesia and is generally associated with limited side effects; however, a few cases with the adverse effect of parkinsonism are reported in the literature. In this study, we report a case of valbenazine‐induced acute parkinsonism.
Yasuhito Nagai +2 more
wiley +1 more source
MANAGEMENT OF DEPRESSION IN THE PRESENCE OF PAIN SYMPTOMS [PDF]
Somatic illness is frequently associated with depression and anxiety and major depression significantly increases risk of severe medical conditions, e.g. cardiovascular illness.
Erich Seifritz +6 more
core +1 more source
Abstract Aim Avoidance is a key maintaining factor in major depressive disorder (MDD); however, longitudinal evidence remains limited, and its association with personality traits is not fully understood. This study aimed to (1) examine the longitudinal associations among avoidance, depressive symptoms, and rumination and (2) explore the relationship ...
Ryotaro Higuchi +9 more
wiley +1 more source
ABSTRACT Introduction High‐risk medications are medications associated with significant patient harm or death if misused or used in error. This study aimed to develop a national consensus high‐risk medication list for use in Australian residential aged care.
Amanda J. Cross +33 more
wiley +1 more source
Mirtazapine for symptom control in refractory gastroparesis
Mark Malamood,1 Aaron Roberts,2 Rahul Kataria,2 Henry P Parkman,2 Ron Schey2 1Department of Internal Medicine, 2Department of Gastroenterology, Temple University Hospital, Philadelphia, PA, USA Introduction: Gastroparesis symptoms can be severe and ...
Malamood M +4 more
doaj
Multiple acyl‐coenzyme A dehydrogenase deficiency‐like disease has recently been described as a rare adverse effect of sertraline. We performed a nationwide population‐based retrospective study in Sweden (2014–2024) including 40 patients, corresponding to an incidence of 1.24 per 100,000 treated individuals per year.
Sofie Sunebo +9 more
wiley +1 more source
Experimental pharmacological research regarding some new quinazolin-4-ones derivatives [PDF]
A series of new compounds with quinazolin-4-one structure, synthesized by the Pharmaceutical Chemistry Department of the Faculty of Pharmacy of the University of Medicine and Pharmacy “Carol Davila” Bucharest, was studied.
Bratu, Mihaela +8 more
core +1 more source
Second Asian Consensus Report on Functional Dyspepsia (2025): Updated Recommendations
ABSTRACT Background Functional dyspepsia (FD) is a common gastrointestinal disorder that significantly impacts patients' quality of life. Over a decade ago, the Asian Neurogastroenterology and Motility Association (ANMA) and the Asian Pacific Association of Gastroenterology (APAGE) jointly developed the first Asian consensus report on FD.
Sanjiv Mahadeva +28 more
wiley +1 more source

